Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
S125924-10mg | 10mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $94.90 | |
S125924-50mg | 50mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $355.90 | |
S125924-100mg | 100mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $664.90 |
ALK inhibitor
Synonyms | 4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide | 4-[4-(1,3-BENZODIOXOL-5-YL)-5-(2-PYRIDINYL)-1H-IMIDAZOL-2-YL]BENZAMIDE | SB431542 | SB-431542 | 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide | SB 431542 |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | SB 431542 is a small molecule that acts as a specific and selective inhibitor of TGFβ RI, ACTR-IB and ACTR-IC (transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, 5, and 7). Renal carcinoma studies have demon |
Storage Temp | Protected from light,Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of activin A receptor type 1C;Inhibitor of transforming growth factor beta receptor 1 |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Product Description | SB431542 is a potent and selective inhibitor of ALK5 with IC50 of 94 nM in a cell-free assay, 100-fold more selective for ALK5 than p38 MAPK and other kinases. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
IUPAC Name | 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide |
---|---|
INCHI | InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26) |
InChi Key | FHYUGAJXYORMHI-UHFFFAOYSA-N |
Canonical SMILES | C1OC2=C(O1)C=C(C=C2)C3=C(NC(=N3)C4=CC=C(C=C4)C(=O)N)C5=CC=CC=N5 |
Isomeric SMILES | C1OC2=C(O1)C=C(C=C2)C3=C(NC(=N3)C4=CC=C(C=C4)C(=O)N)C5=CC=CC=N5 |
PubChem CID | 4521392 |
Molecular Weight | 384.39 |
ChEMBL Ligand | CHEMBL440084 |
---|---|
PubChem CID | 4521392 |
CAS Registry No. | 301836-41-9 |
Wikipedia | SB-431542 |
RCSB PDB Ligand | 85, 085 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
G2430449 | Certificate of Analysis | Jul 16, 2024 | S125924 |
G2430450 | Certificate of Analysis | Jul 16, 2024 | S125924 |
G2430451 | Certificate of Analysis | Jul 16, 2024 | S125924 |
G2430476 | Certificate of Analysis | Jul 16, 2024 | S125924 |
K2125415 | Certificate of Analysis | Sep 11, 2023 | S125924 |
I1509074 | Certificate of Analysis | Mar 17, 2023 | S125924 |
Solubility | Soluble in DMSO (77 mg/ml at 25 °C), ethanol (45 mg/ml at 25 °C), DMF (~20 mg/ml), DMSO:PBS (pH 7.2) (1:1) (~ 0.5 mg/ml), and water (<1 mg/ml at 25 °C). |
---|---|
Sensitivity | Heat sensitive;light sensitive |
Melt Point(°C) | 214 °C(dec.) |
Starting at $169.90
1. Callahan JF, Burgess JL, Fornwald JA, Gaster LM, Harling JD, Harrington FP, Heer J, Kwon C, Lehr R, Mathur A et al.. (2002) Identification of novel inhibitors of the transforming growth factor beta1 (TGF-beta1) type 1 receptor (ALK5).. J Med Chem, 45 (5): (999-1001). [PMID:11855979] |
2. Inman GJ, Nicolás FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS. (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.. Mol Pharmacol, 62 (1): (65-74). [PMID:12065756] |
3. Minutti CM et al.. (2019) A Macrophage-Pericyte Axis Directs Tissue Restoration via Amphiregulin-Induced Transforming Growth Factor Beta Activation.. Immunity, 50 (3): (645-654.e6). [PMID:30770250] |
4. Liberti DC et al.. (2021) Alveolar epithelial cell fate is maintained in a spatially restricted manner to promote lung regeneration after acute injury.. Cell Rep, 35 (6): (109092). [PMID:33979629] |
5. Chen H et al.. (2012) Airway epithelial progenitors are region specific and show differential responses to bleomycin-induced lung injury.. Stem Cells, 30 (9): (1948-60). [PMID:22696116] |
6. André PA et al.. (2015) BARD1 mediates TGF-ß signaling in pulmonary fibrosis.. Respir Res, 16 (118). [PMID:26415510] |
7. Salehi H et al.. (2019) Application of Hanging Drop Culture for Retinal Precursor-Like Cells Differentiation of Human Adipose-Derived Stem Cells Using Small Molecules.. J Mol Neurosci, [PMID:31363912] |
8. Kutsche LK et al.. (2018) Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis.. Cell Syst, 7 (4): (438-452.e8). [PMID:30292704] |
9. Konishi S et al.. (2022) Defined conditions for long-term expansion of murine and human alveolar epithelial stem cells in three-dimensional cultures.. STAR Protoc, 3 (2): (101447). [PMID:35712012] |
10. Abarca-Buis R et al.. (2020) Control of fibrosis by TGFß signalling modulation promotes redifferentiation during limited regeneration of mouse ear.. Int J Dev Biol, 64 (7-8-9): (423-432). [PMID:33063836] |
11. Keatinge M et al.. (2021) CRISPR gRNA phenotypic screening in zebrafish reveals pro-regenerative genes in spinal cord injury.. PLoS Genet, 17 (4): (e1009515). [PMID:33914736] |
12. Xiang Y et al.. (2020) Dysregulation of BRD4 Function Underlies the Functional Abnormalities of MeCP2 Mutant Neurons.. Mol Cell, 79 (84-98.e9). [PMID:32526163] |
13. . (1991) From the Centers for Disease Control. AIDS Clinical Trials Information Service.. JAMA, 266 (13): (1756). [PMID:1653860] |
14. Teisanu RM et al.. (2011) Functional analysis of two distinct bronchiolar progenitors during lung injury and repair.. Am J Respir Cell Mol Biol, 44 (6): (794-803). [PMID:20656948] |
15. Xiang Y et al.. (2018) Generation and Fusion of Human Cortical and Medial Ganglionic Eminence Brain Organoids.. Curr Protoc Stem Cell Biol, 47 [PMID:30854156] |
16. Xiang Y et al.. (2020) Generation of Regionally Specified Human Brain Organoids Resembling Thalamus Development.. STAR Protoc, 1 [PMID:33103124] |
17. Zong W et al.. (2015) Estradiol plays a role in regulating the expression of lysyl oxidase family genes in mouse urogenital tissues and human Ishikawa cells.. J Zhejiang Univ Sci B, 16 (10): (857-64). [PMID:26465133] |
18. Xiang Y et al.. (2019) hESC-Derived Thalamic Organoids Form Reciprocal Projections When Fused with Cortical Organoids.. Cell Stem Cell, 24 (3): (487-497.e7). [PMID:30799279] |
19. Wimmer RA et al.. (2019) Human blood vessel organoids as a\xa0model of\xa0diabetic vasculopathy.. Nature, 565 (7740): (505-510). [PMID:30651639] |
20. Katsura H et al.. (2020) Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction.. Cell Stem Cell, 27 (6): (890-904.e8). [PMID:33128895] |
21. Malaguti M et al.. (2019) Id1 Stabilizes Epiblast Identity by Sensing Delays in Nodal Activation and Adjusting the Timing of Differentiation.. Dev Cell, 50 (4): (462-477.e5). [PMID:31204172] |
22. Khanam R et al.. (2022) Identification of Adamts4 as a novel adult cardiac injury biomarker with therapeutic implications in patients with cardiac injuries.. Sci Rep, 12 (9898). [PMID:35701493] |
23. Ashja-Arvan M et al.. (2020) Impact of IFN-ß and LIF overexpression on human adipose-derived stem cells properties.. J Cell Physiol, [PMID:32324266] |
24. Kim D et al.. (2015) Impaired osteogenesis in Menkes disease-derived induced pluripotent stem cells.. Stem Cell Res Ther, 6 (160). [PMID:26347346] |
25. Sabate-Soler S et al.. (2022) Microglia integration into human midbrain organoids leads to increased neuronal maturation and functionality.. Glia, 70 (7): (1267-1288). [PMID:35262217] |
26. Xu M et al.. (2021) MicroRNA-17-5p restrains the dysfunction of Ang-II induced podocytes by suppressing secreted modular calcium-binding protein 2 via NF-κB and TGFβ signaling.. Environ Toxicol, 36 (7): (1402-1411). [PMID:33835671] |
27. Liu H et al.. (2022) MicroRNA-642b-3p functions as an oncomiR in gastric cancer by down-regulating the CUB and sushi multiple domains protein 1/smad axis.. Bioengineered, 13 (4): (9613-9627). [PMID:35412956] |
28. Zhu K et al.. (2014) MiR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cells.. Sci Rep, 4 (5524). [PMID:25027009] |
29. Hargus G et al.. (2014) Origin-dependent neural cell identities in differentiated human iPSCs in vitro and after transplantation into the mouse brain.. Cell Rep, 8 (6): (1697-703). [PMID:25220454] |
30. Zhang M et al.. (2022) Prkg2 regulates alveolar type 2-mediated re-alveolarization.. Stem Cell Res Ther, 13 (111). [PMID:35313961] |
31. Esteves TC et al.. (2011) Somatic cell nuclear reprogramming of mouse oocytes endures beyond reproductive decline.. Aging Cell, 10 (80-95). [PMID:20969722] |
32. Ateaque S et al.. (2022) Selective activation and down-regulation of Trk receptors by neurotrophins in human neurons co-expressing TrkB and TrkC.. J Neurochem, 161 (6): (463-477). [PMID:35536742] |
33. Yang YH et al.. (2016) Stromal Tissue Rigidity Promotes Mesenchymal Stem Cell-Mediated Corneal Wound Healing Through the Transforming Growth Factor ß Signaling Pathway.. Stem Cells, 34 (10): (2525-2535). [PMID:27250866] |
34. Kelly TJ et al.. (2019) Temporal Control of the TGF-ß Signaling Network by Mouse ESC MicroRNA Targets of Different Affinities.. Cell Rep, 29 (9): (2702-2717.e7). [PMID:31775039] |
35. Kang Y et al.. (2016) Transforming Growth Factor-ß Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors.. Clin Cancer Res, 22 (19): (4934-4946). [PMID:27126993] |
36. Epping MT et al.. (2015) TSPYL2 is an essential component of the REST/NRSF transcriptional complex for TGFß signaling activation.. Cell Death Differ, 22 (8): (1353-62). [PMID:25613376] |